Literature DB >> 21198231

Lower task persistence in smokers with schizophrenia as compared to non-psychiatric control smokers.

Marc L Steinberg1, Jill M Williams1, Kunal K Gandhi1, Jonathan Foulds2, Thomas H Brandon3.   

Abstract

One contributing factor to difficulty in quitting smoking may be task persistence, which can be viewed as a behavioral manifestation of distress tolerance, and describes the act of persisting in a difficult or effortful task. Task persistence was assessed in smokers with schizophrenia and schizoaffective disorder (SZ/SA; N = 71) and non-psychiatric controls (N = 78) before a quit attempt. These data support the hypothesis that smokers with SZ/SA display less task persistence than do non-psychiatric controls when persistence is measured via mirror tracing and a 2-item persistence measure. Lower persistence may partially explain the reduced smoking cessation successes of smokers with SZ/SA as compared to the general population. These data also replicate findings regarding relationships between histories of ability to quit smoking and task persistence and expand them to a new population of smokers. The absence of a diagnostic status by length of previous abstinence interaction suggests that the contribution of task persistence to smoking cessation is similar for smokers with and without schizophrenia. Future studies should evaluate the ability of task persistence to predict abstinence from cigarettes prospectively among smokers with schizophrenia. (PsycINFO Database Record (c) 2010 APA, all rights reserved).

Entities:  

Mesh:

Year:  2010        PMID: 21198231      PMCID: PMC3058670          DOI: 10.1037/a0020972

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  30 in total

1.  Incremental effects of reward on creativity.

Authors:  R Eisenberger; L Rhoades
Journal:  J Pers Soc Psychol       Date:  2001-10

Review 2.  Learned industriousness.

Authors:  R Eisenberger
Journal:  Psychol Rev       Date:  1992-04       Impact factor: 8.934

3.  Relationship between self-reported task persistence and history of quitting smoking, plans for quitting smoking, and current smoking status in adolescents.

Authors:  Marc L Steinberg; Jonathan A Krejci; Kerstin Collett; Thomas H Brandon; Douglas M Ziedonis; Kevin Chen
Journal:  Addict Behav       Date:  2006-11-27       Impact factor: 3.913

4.  Cigarette smoking among adults--United States, 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-11-14       Impact factor: 17.586

5.  Pretreatment task persistence predicts smoking cessation outcome.

Authors:  Thomas H Brandon; Thaddeus A Herzog; Laura M Juliano; Jennifer E Irvin; Amy B Lazev; Vani Nath Simmons
Journal:  J Abnorm Psychol       Date:  2003-08

6.  Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers.

Authors:  A Olincy; D A Young; R Freedman
Journal:  Biol Psychiatry       Date:  1997-07-01       Impact factor: 13.382

7.  Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia.

Authors:  Taryn G Moss; Kristi A Sacco; Taryn M Allen; Andrea H Weinberger; Jennifer C Vessicchio; Tony P George
Journal:  Drug Alcohol Depend       Date:  2009-05-17       Impact factor: 4.492

8.  Tobacco use among those with serious psychological distress: results from the national survey of drug use and health, 2002.

Authors:  Brett T Hagman; Cristine D Delnevo; Mary Hrywna; Jill M Williams
Journal:  Addict Behav       Date:  2007-11-17       Impact factor: 3.913

9.  A prospective examination of distress tolerance and early smoking lapse in adult self-quitters.

Authors:  Richard A Brown; C W Lejuez; David R Strong; Christopher W Kahler; Michael J Zvolensky; Linda L Carpenter; Raymond Niaura; Lawrence H Price
Journal:  Nicotine Tob Res       Date:  2009-04-16       Impact factor: 4.244

10.  A prospective study of persistence in the prediction of smoking cessation outcome: results from a randomized clinical trial.

Authors:  David Kalman; Randall Hoskinson; Usha Sambamoorthi; Arthur J Garvey
Journal:  Addict Behav       Date:  2009-09-22       Impact factor: 3.913

View more
  7 in total

1.  Task persistence predicts smoking cessation in smokers with and without schizophrenia.

Authors:  Marc L Steinberg; Jill M Williams; Kunal K Gandhi; Jonathan Foulds; Elizabeth E Epstein; Thomas H Brandon
Journal:  Psychol Addict Behav       Date:  2012-05-28

2.  State, but not trait, measures of persistence are related to negative affect.

Authors:  Marc L Steinberg; Jill M Williams
Journal:  J Stud Alcohol Drugs       Date:  2013-07       Impact factor: 2.582

3.  A novel intervention increases task persistence in smokers with schizophrenia: A proof of concept study.

Authors:  Marc L Steinberg; Benjamin Billingsley; Rachel L Rosen; Elizabeth E Epstein; Shou-En Lu; Jill M Williams
Journal:  Schizophr Res       Date:  2019-10-12       Impact factor: 4.939

Review 4.  Exploring Issues of Comorbid Conditions in People Who Smoke.

Authors:  Alana M Rojewski; Stephen Baldassarri; Nina A Cooperman; Ellen R Gritz; Frank T Leone; Megan E Piper; Benjamin A Toll; Graham W Warren
Journal:  Nicotine Tob Res       Date:  2016-01-17       Impact factor: 4.244

5.  Cognitive persistence: Development and validation of a novel measure from the Wisconsin Card Sorting Test.

Authors:  Susan Teubner-Rhodes; Kenneth I Vaden; Judy R Dubno; Mark A Eckert
Journal:  Neuropsychologia       Date:  2017-05-25       Impact factor: 3.139

6.  Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia.

Authors:  Jill M Williams; Kunal K Gandhi; Shou-En Lu; Supriya Kumar; Marc L Steinberg; Brett Cottler; Neal L Benowitz
Journal:  Drug Alcohol Depend       Date:  2011-05-18       Impact factor: 4.492

7.  Smoking Topography Characteristics of Very Low Nicotine Content Cigarettes, With and Without Nicotine Replacement, in Smokers With Schizophrenia and Controls.

Authors:  Jennifer W Tidey; Rachel N Cassidy; Mollie E Miller
Journal:  Nicotine Tob Res       Date:  2016-03-19       Impact factor: 4.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.